Abattis Bioceuticals Minority Interest

Abattis Bioceuticals's minority interest stands at $-410K as of September 2019. That compares with $-390K in the prior-year period — down 4.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Abattis Bioceuticals reported $-410K in minority interest versus $-390K a year earlier — a 4.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $-390K in the prior-year period — down 4.9% year over year. Sustained growth in minority interest can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Abattis Bioceuticals's minority interest evolved across reporting periods, while the comparison chart places ATTBF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, minority interest is commonly used to spot outliers. Abattis Bioceuticals's reading of $-410K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.